Imaging intra-arterial hepatic port catheter systems by power-Doppler sonography using contrast media - Preliminary results;Darstellung intraarterieller Leberports mittels kontrastmittelgestutzter Powerdopplersonographie - Erste ergebnisse

Ultraschall in der Medizin

Volumn 21, Issue 4, 2000, Pages 176-179

  Puls, R ^a   Stroszczynski, C ^a   Hildebrandt, B ^b   Hosten, N ^a   Bechstein, W O ^b   Riess, H ^b   Felix, R ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Levovist(TM); Liver port system; Power Doppler; Ultrasound contrast media

Indexed keywords

CONTRAST MEDIUM; SHU 508;

ADULT; AGED; ARTERY BLOOD FLOW; ARTICLE; CLINICAL ARTICLE; CONTRAST RADIOGRAPHY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DOPPLER FLOWMETRY; FEMALE; HEPATIC ARTERY; HEPATOBILIARY SYSTEM; HUMAN; MALE; SPLEEN ARTERY; BLOOD FLOW; CATHETERIZATION; ECHOGRAPHY; INDWELLING CATHETER; LIVER CIRCULATION; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY;

AGED; CATHETERIZATION, PERIPHERAL; CATHETERS, INDWELLING; CONTRAST MEDIA; FEMALE; HEPATIC ARTERY; HUMANS; LIVER CIRCULATION; MALE; MIDDLE AGED; REGIONAL BLOOD FLOW; SPLENIC ARTERY; ULTRASONOGRAPHY, DOPPLER;

EID: 0033623392     PISSN: 01724614     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-6922     Document Type: Article

References (6)

1. Intraprocedural myocardial contrast echocardiography as a routine procedure in percutaneous transluminal septal myocardial ablation: Detection of threatening myocardial necrosis distant from the septal target area
2. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Results with respect to intraprocedural myocardial contrast echocardiography
3. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer
4. Port visualization before intra-peritoneal chemotherapy: Scintigraphy?
5. Arterielle Leberversorgung: Erkennbarkeit mittels farbkodierter Dopplersonographie vor und nach Levovist®-Injektion
6. A multicenter, prospective, open label, randomized, controlled phase IIIb study of SH U 508a (Levovist) for Doppler signal enhancement in the portal vascular system